Koninklijke Philips N.V. (NYSE: PHG) Stock Competitors & Peer Comparison
See PHG's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHG and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHG | $27.38 | +2.16% | 26.8B | 15.64 | $1.75 | +3.62% |
| ABT | $111.27 | +0.32% | 192.6B | 21.36 | $5.21 | +2.23% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $341.09 | -1.76% | 130.8B | 25.47 | $13.39 | +1.02% |
| MDT | $90.58 | -0.20% | 116B | 16.38 | $5.53 | +3.14% |
| BSX | $51.69 | +0.53% | 76.9B | 16.68 | $3.10 | N/A |
| EW | $92.56 | -0.53% | 53.3B | 34.29 | $2.70 | N/A |
| DXCM | $91.48 | +0.75% | 34.5B | 39.26 | $2.33 | N/A |
| RMD | $226.74 | +0.33% | 32.9B | 21.06 | $10.77 | +1.05% |
| ZBH | $99.57 | +1.72% | 19.3B | 11.74 | $8.48 | +0.97% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
PHG vs ABT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ABT trades at $111.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ABT's P/E ratio is 21.36. In terms of profitability, PHG's ROE is +0.10%, compared to ABT's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
PHG vs BSX-PA Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, PHG's ROE is +0.10%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
PHG vs SYK Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SYK has a market cap of 130.8B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SYK trades at $341.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SYK's P/E ratio is 25.47. In terms of profitability, PHG's ROE is +0.10%, compared to SYK's ROE of +0.16%. Regarding short-term risk, PHG is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SYK's competition here
Medtronic plc (NYSE: MDT)
PHG vs MDT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, MDT has a market cap of 116B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while MDT trades at $90.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas MDT's P/E ratio is 16.38. In terms of profitability, PHG's ROE is +0.10%, compared to MDT's ROE of +0.10%. Regarding short-term risk, PHG is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
PHG vs BSX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BSX has a market cap of 76.9B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BSX trades at $51.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BSX's P/E ratio is 16.68. In terms of profitability, PHG's ROE is +0.10%, compared to BSX's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
PHG vs EW Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, EW has a market cap of 53.3B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while EW trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas EW's P/E ratio is 34.29. In terms of profitability, PHG's ROE is +0.10%, compared to EW's ROE of +0.10%. Regarding short-term risk, PHG is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for PHG.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
PHG vs DXCM Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while DXCM trades at $91.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas DXCM's P/E ratio is 39.26. In terms of profitability, PHG's ROE is +0.10%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, PHG is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
PHG vs RMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, RMD has a market cap of 32.9B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while RMD trades at $226.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas RMD's P/E ratio is 21.06. In terms of profitability, PHG's ROE is +0.10%, compared to RMD's ROE of +0.24%. Regarding short-term risk, PHG is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check RMD's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
PHG vs ZBH Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ZBH trades at $99.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ZBH's P/E ratio is 11.74. In terms of profitability, PHG's ROE is +0.10%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, PHG is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
PHG vs ABMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ABMD's P/E ratio is 65.36. In terms of profitability, PHG's ROE is +0.10%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, PHG is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
PHG vs PEN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PEN trades at $326.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PEN's P/E ratio is 85.36. In terms of profitability, PHG's ROE is +0.10%, compared to PEN's ROE of +0.11%. Regarding short-term risk, PHG is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for PHG.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
PHG vs SNN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SNN has a market cap of 12.7B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SNN's P/E ratio is 14.17. In terms of profitability, PHG's ROE is +0.10%, compared to SNN's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
PHG vs ALGN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ALGN has a market cap of 12.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ALGN trades at $176.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ALGN's P/E ratio is 16.06. In terms of profitability, PHG's ROE is +0.10%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, PHG is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ALGN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
PHG vs SWAV Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SWAV's P/E ratio is 78.76. In terms of profitability, PHG's ROE is +0.10%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, PHG is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SWAV's competition here
Globus Medical, Inc. (NYSE: GMED)
PHG vs GMED Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while GMED trades at $85.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas GMED's P/E ratio is 19.36. In terms of profitability, PHG's ROE is +0.10%, compared to GMED's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for PHG.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
PHG vs GKOS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while GKOS trades at $189.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas GKOS's P/E ratio is -220.30. In terms of profitability, PHG's ROE is +0.10%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, PHG is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
PHG vs PODD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PODD trades at $146.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PODD's P/E ratio is 24.95. In terms of profitability, PHG's ROE is +0.10%, compared to PODD's ROE of +0.27%. Regarding short-term risk, PHG is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
PHG vs BIO Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BIO trades at $361.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BIO's P/E ratio is 38.93. In terms of profitability, PHG's ROE is +0.10%, compared to BIO's ROE of +0.03%. Regarding short-term risk, PHG is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
PHG vs BIO-B Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BIO-B trades at $348.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, PHG's ROE is +0.10%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, PHG is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for PHG.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
PHG vs MASI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas MASI's P/E ratio is 44.43. In terms of profitability, PHG's ROE is +0.10%, compared to MASI's ROE of +0.09%. Regarding short-term risk, PHG is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for PHG.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
PHG vs BRKR Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BRKR trades at $57.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BRKR's P/E ratio is 29.11. In terms of profitability, PHG's ROE is +0.10%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, PHG is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
PHG vs NARI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas NARI's P/E ratio is -59.24. In terms of profitability, PHG's ROE is +0.10%, compared to NARI's ROE of -0.00%. Regarding short-term risk, PHG is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for PHG.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
PHG vs LIVN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while LIVN trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas LIVN's P/E ratio is 19.19. In terms of profitability, PHG's ROE is +0.10%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
PHG vs ITGR Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ITGR trades at $125.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ITGR's P/E ratio is 19.69. In terms of profitability, PHG's ROE is +0.10%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, PHG is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
PHG vs HAE Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while HAE trades at $90.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas HAE's P/E ratio is 18.06. In terms of profitability, PHG's ROE is +0.10%, compared to HAE's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for PHG.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
PHG vs IRTC Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while IRTC trades at $123.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas IRTC's P/E ratio is -192.44. In terms of profitability, PHG's ROE is +0.10%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, PHG is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
PHG vs AXNX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AXNX's P/E ratio is -709.80. In terms of profitability, PHG's ROE is +0.10%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, PHG is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
PHG vs TMDX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while TMDX trades at $89.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas TMDX's P/E ratio is 45.50. In terms of profitability, PHG's ROE is +0.10%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, PHG is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
PHG vs AXGN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AXGN trades at $48.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AXGN's P/E ratio is 126.45. In terms of profitability, PHG's ROE is +0.10%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, PHG is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
PHG vs UFPT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while UFPT trades at $319.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas UFPT's P/E ratio is 32.67. In terms of profitability, PHG's ROE is +0.10%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, PHG is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
PHG vs BFLY Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BFLY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BFLY's P/E ratio is -36.79. In terms of profitability, PHG's ROE is +0.10%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, PHG is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
PHG vs ESTA Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ESTA trades at $75.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ESTA's P/E ratio is -59.99. In terms of profitability, PHG's ROE is +0.10%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, PHG is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
PHG vs NUVA Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas NUVA's P/E ratio is 75.00. In terms of profitability, PHG's ROE is +0.10%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, PHG is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
PHG vs NVCR Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while NVCR trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas NVCR's P/E ratio is -11.36. In terms of profitability, PHG's ROE is +0.10%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, PHG is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
PHG vs INSP Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while INSP trades at $58.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas INSP's P/E ratio is 25.62. In terms of profitability, PHG's ROE is +0.10%, compared to INSP's ROE of +0.18%. Regarding short-term risk, PHG is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
PHG vs TNDM Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while TNDM trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas TNDM's P/E ratio is -21.03. In terms of profitability, PHG's ROE is +0.10%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, PHG is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
PHG vs ATEC Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ATEC trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ATEC's P/E ratio is -162.50. In terms of profitability, PHG's ROE is +0.10%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, PHG is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
PHG vs CNMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CNMD trades at $49.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CNMD's P/E ratio is 10.94. In terms of profitability, PHG's ROE is +0.10%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, PHG is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
PHG vs ENOV Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ENOV trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ENOV's P/E ratio is 7.36. In terms of profitability, PHG's ROE is +0.10%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, PHG is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
PHG vs IART Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while IART trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas IART's P/E ratio is 7.73. In terms of profitability, PHG's ROE is +0.10%, compared to IART's ROE of -0.01%. Regarding short-term risk, PHG is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
PHG vs AORT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AORT trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AORT's P/E ratio is 47.38. In terms of profitability, PHG's ROE is +0.10%, compared to AORT's ROE of -0.01%. Regarding short-term risk, PHG is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
PHG vs HSKA Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas HSKA's P/E ratio is -62.49. In terms of profitability, PHG's ROE is +0.10%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, PHG is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for PHG.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
PHG vs PRCT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PRCT trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PRCT's P/E ratio is -11.31. In terms of profitability, PHG's ROE is +0.10%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, PHG is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
PHG vs AVNS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AVNS's P/E ratio is 27.77. In terms of profitability, PHG's ROE is +0.10%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, PHG is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for PHG.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
PHG vs LMRI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while LMRI trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas LMRI's P/E ratio is -22.82. In terms of profitability, PHG's ROE is +0.10%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, PHG is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
PHG vs SILK Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SILK's P/E ratio is -18.96. In terms of profitability, PHG's ROE is +0.10%, compared to SILK's ROE of -0.35%. Regarding short-term risk, PHG is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
PHG vs IRMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while IRMD trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas IRMD's P/E ratio is 43.80. In terms of profitability, PHG's ROE is +0.10%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, PHG is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
PHG vs FNA Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas FNA's P/E ratio is -19.83. In terms of profitability, PHG's ROE is +0.10%, compared to FNA's ROE of -0.35%. Regarding short-term risk, PHG is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for PHG.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
PHG vs BVS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BVS has a market cap of 941M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BVS trades at $13.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BVS's P/E ratio is 18.28. In terms of profitability, PHG's ROE is +0.10%, compared to BVS's ROE of +0.28%. Regarding short-term risk, PHG is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
PHG vs CBLL Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CBLL has a market cap of 882.2M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CBLL trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CBLL's P/E ratio is -14.26. In terms of profitability, PHG's ROE is +0.10%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, PHG is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CBLL's competition here
InMode Ltd. (NASDAQ: INMD)
PHG vs INMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, INMD has a market cap of 873.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while INMD trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas INMD's P/E ratio is 10.56. In terms of profitability, PHG's ROE is +0.10%, compared to INMD's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
PHG vs AVR Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AVR has a market cap of 868.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AVR trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AVR's P/E ratio is -4.00. In terms of profitability, PHG's ROE is +0.10%, compared to AVR's ROE of -0.78%. Regarding short-term risk, PHG is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
PHG vs CSII Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CSII's P/E ratio is -20.83. In terms of profitability, PHG's ROE is +0.10%, compared to CSII's ROE of -0.14%. Regarding short-term risk, PHG is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for PHG.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
PHG vs SIBN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SIBN has a market cap of 840.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SIBN trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SIBN's P/E ratio is -55.74. In terms of profitability, PHG's ROE is +0.10%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, PHG is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SIBN's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
PHG vs BBNX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BBNX has a market cap of 813.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BBNX trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BBNX's P/E ratio is -11.97. In terms of profitability, PHG's ROE is +0.10%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, PHG is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
PHG vs VREX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, VREX has a market cap of 778.9M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas VREX's P/E ratio is 19.47. In terms of profitability, PHG's ROE is +0.10%, compared to VREX's ROE of +0.05%. Regarding short-term risk, PHG is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
PHG vs AHCO Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while AHCO trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas AHCO's P/E ratio is 11.63. In terms of profitability, PHG's ROE is +0.10%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, PHG is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
PHG vs SSII Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SSII has a market cap of 766.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SSII trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SSII's P/E ratio is -74.70. In terms of profitability, PHG's ROE is +0.10%, compared to SSII's ROE of -0.27%. Regarding short-term risk, PHG is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SSII's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
PHG vs BWAY Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BWAY has a market cap of 646M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BWAY trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BWAY's P/E ratio is 41.84. In terms of profitability, PHG's ROE is +0.10%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
PHG vs KIDS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, KIDS has a market cap of 642.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while KIDS trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas KIDS's P/E ratio is -21.19. In terms of profitability, PHG's ROE is +0.10%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, PHG is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
PHG vs CTKB Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CTKB trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CTKB's P/E ratio is -25.91. In terms of profitability, PHG's ROE is +0.10%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, PHG is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
PHG vs SRDX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SRDX's P/E ratio is -34.66. In terms of profitability, PHG's ROE is +0.10%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, PHG is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SRDX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
PHG vs DCTH Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while DCTH trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, PHG's ROE is +0.10%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, PHG is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for PHG.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
PHG vs APEN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas APEN's P/E ratio is -9.43. In terms of profitability, PHG's ROE is +0.10%, compared to APEN's ROE of -0.85%. Regarding short-term risk, PHG is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for PHG.Check APEN's competition here
Cerus Corporation (NASDAQ: CERS)
PHG vs CERS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CERS has a market cap of 572.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CERS trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CERS's P/E ratio is -56.69. In terms of profitability, PHG's ROE is +0.10%, compared to CERS's ROE of -0.10%. Regarding short-term risk, PHG is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
PHG vs ZIMV Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, PHG's ROE is +0.10%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, PHG is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
PHG vs TCMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, TCMD has a market cap of 534.8M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while TCMD trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas TCMD's P/E ratio is 26.94. In terms of profitability, PHG's ROE is +0.10%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
PHG vs NPCE Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, NPCE has a market cap of 494.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while NPCE trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas NPCE's P/E ratio is -22.32. In terms of profitability, PHG's ROE is +0.10%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, PHG is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
PHG vs CLPT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CLPT has a market cap of 462.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CLPT trades at $15.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CLPT's P/E ratio is -13.07. In terms of profitability, PHG's ROE is +0.10%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, PHG is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
PHG vs SGHT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SGHT has a market cap of 452.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SGHT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SGHT's P/E ratio is -14.86. In terms of profitability, PHG's ROE is +0.10%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, PHG is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
PHG vs OFIX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, OFIX has a market cap of 411.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while OFIX trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas OFIX's P/E ratio is -13.30. In terms of profitability, PHG's ROE is +0.10%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, PHG is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
PHG vs CARL Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CARL has a market cap of 380.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CARL trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CARL's P/E ratio is -9.78. In terms of profitability, PHG's ROE is +0.10%, compared to CARL's ROE of -0.38%. Regarding short-term risk, PHG is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
PHG vs PACB Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PACB trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PACB's P/E ratio is -2.80. In terms of profitability, PHG's ROE is +0.10%, compared to PACB's ROE of -49.62%. Regarding short-term risk, PHG is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PACB's competition here
Picard Medical, Inc. (AMEX: PMI)
PHG vs PMI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PMI has a market cap of 354.8M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PMI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PMI's P/E ratio is -2.88. In terms of profitability, PHG's ROE is +0.10%, compared to PMI's ROE of +4.99%. Regarding short-term risk, PHG is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PMI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
PHG vs CATX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CATX has a market cap of 352.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CATX's P/E ratio is -2.19. In terms of profitability, PHG's ROE is +0.10%, compared to CATX's ROE of -0.42%. Regarding short-term risk, PHG is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CATX's competition here
Electromed, Inc. (AMEX: ELMD)
PHG vs ELMD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ELMD has a market cap of 351.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ELMD trades at $42.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ELMD's P/E ratio is 36.24. In terms of profitability, PHG's ROE is +0.10%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, PHG is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
PHG vs TLSI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, TLSI has a market cap of 346.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while TLSI trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas TLSI's P/E ratio is -3.35. In terms of profitability, PHG's ROE is +0.10%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, PHG is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
PHG vs CV Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while CV trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas CV's P/E ratio is -2.72. In terms of profitability, PHG's ROE is +0.10%, compared to CV's ROE of +1.27%. Regarding short-term risk, PHG is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
PHG vs SENS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SENS has a market cap of 323.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SENS trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SENS's P/E ratio is -3.86. In terms of profitability, PHG's ROE is +0.10%, compared to SENS's ROE of -1.66%. Regarding short-term risk, PHG is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SENS's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
PHG vs SMLR Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas SMLR's P/E ratio is 3.92. In terms of profitability, PHG's ROE is +0.10%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, PHG is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
PHG vs TMCI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas TMCI's P/E ratio is -4.80. In terms of profitability, PHG's ROE is +0.10%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, PHG is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TMCI's competition here
RxSight, Inc. (NASDAQ: RXST)
PHG vs RXST Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, RXST has a market cap of 290.2M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while RXST trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas RXST's P/E ratio is -7.54. In terms of profitability, PHG's ROE is +0.10%, compared to RXST's ROE of -0.17%. Regarding short-term risk, PHG is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for PHG.Check RXST's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
PHG vs ANIK Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ANIK has a market cap of 283.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ANIK trades at $21.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ANIK's P/E ratio is 43.20. In terms of profitability, PHG's ROE is +0.10%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, PHG is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ANIK's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
PHG vs MGRM Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas MGRM's P/E ratio is -12.00. In terms of profitability, PHG's ROE is +0.10%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, PHG is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for PHG.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
PHG vs PROF Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, PROF has a market cap of 242.4M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while PROF trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas PROF's P/E ratio is -5.38. In terms of profitability, PHG's ROE is +0.10%, compared to PROF's ROE of -0.56%. Regarding short-term risk, PHG is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PROF's competition here
Nevro Corp. (NYSE: NVRO)
PHG vs NVRO Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas NVRO's P/E ratio is -1.91. In terms of profitability, PHG's ROE is +0.10%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, PHG is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for PHG.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
PHG vs STIM Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while STIM trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas STIM's P/E ratio is -5.61. In terms of profitability, PHG's ROE is +0.10%, compared to STIM's ROE of -1.51%. Regarding short-term risk, PHG is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check STIM's competition here
Avita Medical Inc. (NASDAQ: RCEL)
PHG vs RCEL Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, RCEL has a market cap of 199M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while RCEL trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas RCEL's P/E ratio is -5.10. In terms of profitability, PHG's ROE is +0.10%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, PHG is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
PHG vs BSGM Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas BSGM's P/E ratio is -5.81. In terms of profitability, PHG's ROE is +0.10%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, PHG is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
PHG vs LUCD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, LUCD has a market cap of 184.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas LUCD's P/E ratio is -2.61. In terms of profitability, PHG's ROE is +0.10%, compared to LUCD's ROE of -0.02%. Regarding short-term risk, PHG is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
PHG vs MDGS Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas MDGS's P/E ratio is -0.27. In terms of profitability, PHG's ROE is +0.10%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, PHG is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
PHG vs FOCL Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while FOCL trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas FOCL's P/E ratio is -5.80. In terms of profitability, PHG's ROE is +0.10%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, PHG is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
PHG vs QIPT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas QIPT's P/E ratio is -15.87. In terms of profitability, PHG's ROE is +0.10%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, PHG is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for PHG.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
PHG vs INGN Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while INGN trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas INGN's P/E ratio is -6.38. In terms of profitability, PHG's ROE is +0.10%, compared to INGN's ROE of -0.13%. Regarding short-term risk, PHG is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
PHG vs QTRX Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, QTRX has a market cap of 134.7M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while QTRX trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas QTRX's P/E ratio is -1.79. In terms of profitability, PHG's ROE is +0.10%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, PHG is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
PHG vs OWLT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, OWLT has a market cap of 114.5M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while OWLT trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas OWLT's P/E ratio is -45.21. In terms of profitability, PHG's ROE is +0.10%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, PHG is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
PHG vs ICAD Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas ICAD's P/E ratio is -20.37. In terms of profitability, PHG's ROE is +0.10%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, PHG is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ICAD's competition here
Solana Company (NASDAQ: HSDT)
PHG vs HSDT Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, HSDT has a market cap of 105.1M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while HSDT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas HSDT's P/E ratio is -0.02. In terms of profitability, PHG's ROE is +0.10%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, PHG is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
PHG vs HJLI Comparison August 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 26.8B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, PHG is priced at $27.38 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.64, whereas HJLI's P/E ratio is N/A. In terms of profitability, PHG's ROE is +0.10%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, PHG is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check HJLI's competition here